Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.430

-0.010 (-0.69%)

At close: Dec 5, 2025, 4:00 PM EST

1.420

-0.010 (-0.70%)

After-hours: Dec 5, 2025, 6:22 PM EST

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $321.36 million as of December 5, 2025. Its market cap has decreased by -27.70% in one year.

Market Cap

321.36M

Enterprise Value

154.31M

1-Year Change

-27.70%

Ranking

#3423

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $321.36M, a decrease of -88.84%. That is a compound annual growth rate of -26.40%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	321.36M	-28.04%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	904.62B
Johnson & Johnson	486.51B
AbbVie	399.57B
UnitedHealth Group	299.75B
AstraZeneca	280.82B
Novartis AG	255.15B
Merck & Co.	247.51B
Abbott Laboratories	217.50B

Market Cap Rankings